A detailed history of Lpl Financial LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 14,342 shares of INMB stock, worth $64,395. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,342
Previous 13,397 7.05%
Holding current value
$64,395
Previous $118,000 34.75%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$4.86 - $9.86 $4,592 - $9,317
945 Added 7.05%
14,342 $77,000
Q2 2024

Aug 07, 2024

BUY
$7.15 - $11.84 $24,131 - $39,960
3,375 Added 33.68%
13,397 $118,000
Q1 2024

May 10, 2024

SELL
$10.53 - $14.01 $789 - $1,050
-75 Reduced 0.74%
10,022 $117,000
Q3 2023

Nov 13, 2023

BUY
$6.61 - $10.9 $66,741 - $110,057
10,097 New
10,097 $68,000

Others Institutions Holding INMB

About Inmune Bio, Inc.


  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $80.6M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.